KINAXO
Key Facts
| Invested since | 2006 |
| Based in | Bavaria |
About the company
KINAXO supports pharmaceutical companies in the development of targeted drugs and predictive biomarkers for personalized healthcare.
Exit since Feb. 2011. Purchaser: Evotec AG
Do you want to
know more about this company?
KINAXO in the news
More startups from Life Sciences
Skinuvita is a digital care model for the home use of phototherapy for chronic skin conditions such as psoriasis and neurodermatitis. With the innovative telemedicine system, the prescribed dose is …
to Skinuvita
TolerogenixX GmbH has developed a patented and clinically tested cell therapy technique for individualised immunosuppression in transplant patients. The technique enables the targeted disabling of undesired reactions caused by the …
to TolerogenixX
neotiv is a spin-off of the Otto von Guericke University in the German city of Magdeburg in close collaboration with the Magdeburg site of the German Centre for Neurodegenerative Diseases …
to neotiv
VACIS is the leading tissue engineering company for body-own blood vessels. The VACIS technology uses a synthetic rod which induces the formation of a new fully functional blood vessel providing …
to Vacis
Exit
First-in-class Entry-Inhibitor for the treatment of chronic hepatitis Delta
to MYR
TRIM TX is developing best-in-class Gamma-Secretase-Stabilizers (GSS) for the prevention and treatment of Alzheimer Disease.
to TRIM TX
Treatment of sustainable plaque in coronary arteries through our proprietary catheter based device.
to Cryotherapeutics
Symphera is a Munich-based startup that is revolutionizing laparoscopic surgery with an innovative system designed to eliminate the need for manual instrument changes. Founded in 2023, Symphera was incubated at …
to Symphera
WMT developes small molecules for cancer indications by targeting the Warburg Metabolism. The Warburg Metabolism was first described 100 years ago by Otto Heinrich Warburg and the therapeutic approach is …
to WMT
Exit
Lipocalyx develops transfection reagents. Our Viromers® are polymers emulating a viral mechanism for cell entry. The company provides reagents and currently establishes services for pharmaceutical applications.
to Lipocalyx
AudioCure Pharma is an innovative clinical-stage pharmaceutical company focused on developing treatments for audiological and neurological disorders with a high unmet medical need. Our small molecules have shown Proof-of-Principle in …
to AudioCure
Exit
Modern therapeutic approaches face the challenge to combine efficacy, low undesired side effects and reasonable pricing. Therefore, drug substances become more and more complex, therapies become more personalized while overall …
to Belyntic